IP Library › Granted Patent US 8,748,179
Granted Patent B2
US 8,748,179 · App. 13/393,080 · Granted Jun 10, 2014

Method for efficient production of induced pluripotent stem cells utilizing cells derived from oral mucosa

Inventors: Hiroshi Egusa (Osaka, JP); Hirofumi Yatani (Osaka, JP); Hiroki Kayashima (Osaka, JP)
Assignee: Osaka University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,748,179
App. No.
13/393,080
Granted
Jun 10, 2014
Kind
B2
Abstract

A main object of the present invention is to provide a technique to produce iPS cells with less burden on the patient and with high establishment efficiency. iPS cells can be efficiently produced with significantly improved establishment efficiency by selecting cells derived from oral mucosa and introducing, into the cells, reprogramming factors capable of inducing the cells into pluripotent stem cells.

Claims (2)

1. A method for producing mouse or human induced pluripotent stem cells, comprising a step of introducing a vector encoding reprogramming factors Oct 3/4, Sox2, and Klf4 into mouse or human gingival fibroblasts, wherein expression of the reprogramming factors in the gingival fibroblasts induces reprogramming of said gingival fibroblasts into pluripotent stem cells, thereby producing mouse or human induced pluripotent stem cells.

2. The production method according to claim 1 , wherein the reprogramming factors further comprise a Myc family gene.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2012
From: EGUSA, HIROSHI; YATANI, HIROFUMI; KAYASHIMA, HIROKI
To: OSAKA UNIVERSITY
Reel/Frame 027776/0931 →
Priority Claims (1)
JP 2009-200932 · Aug 31, 2009 · national
Continuity (1)
Related Publication 20120156778A1 · Jun 21, 2012